News

Increasing irisin, found at lower levels in people with PAH, may help slow disease progression by stopping vascular ...
A protein called BMPER found at low levels in models has emerged as a PAH treatment target as it may ease disease progression ...
Telisotuzumab vedotin-tllv “is the first and only treatment approved for previously treated advanced NSCLC patients with high c-Met protein overexpression who often face poor prognosis and have ...
The FIGHT study reported a prevalence of FGFR2b protein overexpression in any percentage of TC in 29% of prescreened patients. 16 Determining the prevalence of FGFR2b protein overexpression in a large ...
image: Overexpression of the SRSF6 gene in mice leads tissue to display the molecular signatures of wound-healing (right panel). These signatures are evident when one compares tissue in which the ...
Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian cancers (AOC). Trastuzumab, tested only as a single agent, has been shown to ...
The LUMINOSITY trial demonstrated a 35% overall response rate (95% CI, 24-46) and a duration of response of 7.2 months on average (95% CI, 4.2-12) among the 84 patients with high c-Met protein ...
Chronic heart failure resulting from dilated cardiomyopathy is rapidly emerging as a disease of epidemic proportions.1 Molecular mechanisms are being studied and advances have been made in a ...
Overexpression of splicing protein in skin repair causes early changes seen in skin cancer. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2014 / 01 / 140119142446.htm.